$CRTX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cortexyme, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Cortexyme, Inc.. Get notifications about new insider transactions in Cortexyme, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2021 | CRTX | Cortexyme, Inc. | Senner Christopher J. | Director | Option Exercise | A | 50.56 | 11,029 | 557,626 | 11,029 | |
May 12 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 36.73 | 183 | 6,722 | 978,774 | 979 K to 978.8 K (-0.02 %) |
May 12 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 35.81 | 6,315 | 226,140 | 978,957 | 985.3 K to 979 K (-0.64 %) |
May 12 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 36.73 | 183 | 6,722 | 978,774 | 979 K to 978.8 K (-0.02 %) |
May 12 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 34.89 | 9,918 | 346,039 | 985,272 | 995.2 K to 985.3 K (-1.00 %) |
May 12 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 35.81 | 6,315 | 226,140 | 978,957 | 985.3 K to 979 K (-0.64 %) |
May 12 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 33.75 | 13,584 | 458,460 | 995,190 | 1 M to 995.2 K (-1.35 %) |
May 12 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 34.89 | 9,918 | 346,039 | 985,272 | 995.2 K to 985.3 K (-1.00 %) |
May 12 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 33.75 | 13,584 | 458,460 | 995,190 | 1 M to 995.2 K (-1.35 %) |
Mar 24 2021 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 33.77 | 50,000 | 1,688,500 | 1,847,109 | 1.8 M to 1.8 M (+2.78 %) |
Mar 24 2021 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 33.77 | 50,000 | 1,688,500 | 1,847,109 | 1.8 M to 1.8 M (+2.78 %) |
Mar 23 2021 | CRTX | Cortexyme, Inc. | Lamond David | Director | Gift | G | 0.00 | 1,534,720 | 0 | 1,534,720 | 0 to 1.5 M |
Mar 23 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 36.60 | 400 | 14,640 | 1,008,774 | 1 M to 1 M (-0.04 %) |
Mar 23 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 36.58 | 300 | 10,974 | 1,009,174 | 1 M to 1 M (-0.03 %) |
Mar 23 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 35.85 | 18,089 | 648,491 | 1,009,474 | 1 M to 1 M (-1.76 %) |
Mar 23 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 35.10 | 11,211 | 393,506 | 1,027,563 | 1 M to 1 M (-1.08 %) |
Mar 05 2021 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 36.86 | 4,100 | 151,126 | 1,797,109 | 1.8 M to 1.8 M (+0.23 %) |
Mar 05 2021 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 36.34 | 15,969 | 580,313 | 1,793,009 | 1.8 M to 1.8 M (+0.90 %) |
Mar 05 2021 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 35.00 | 13,310 | 465,850 | 1,777,040 | 1.8 M to 1.8 M (+0.75 %) |
Mar 05 2021 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 34.28 | 16,621 | 569,768 | 1,763,730 | 1.7 M to 1.8 M (+0.95 %) |
Feb 11 2021 | CRTX | Cortexyme, Inc. | Monohon Ted | Chief Accounting Of ... | Option Exercise | A | 46.10 | 20,000 | 922,000 | 20,000 | |
Feb 11 2021 | CRTX | Cortexyme, Inc. | LOWE CHRISTOPHER P. | COO & Chief Financi ... | Option Exercise | A | 46.10 | 40,000 | 1,844,000 | 40,000 | |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 45.73 | 600 | 27,438 | 1,038,774 | 1 M to 1 M (-0.06 %) |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 45.00 | 8,032 | 361,440 | 1,039,374 | 1 M to 1 M (-0.77 %) |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 44.22 | 1,900 | 84,018 | 1,047,406 | 1 M to 1 M (-0.18 %) |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 43.10 | 1,512 | 65,167 | 1,049,306 | 1.1 M to 1 M (-0.14 %) |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 41.91 | 3,100 | 129,921 | 1,050,818 | 1.1 M to 1.1 M (-0.29 %) |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 40.84 | 2,000 | 81,680 | 1,053,918 | 1.1 M to 1.1 M (-0.19 %) |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 39.82 | 856 | 34,086 | 1,055,918 | 1.1 M to 1.1 M (-0.08 %) |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 38.64 | 1,600 | 61,824 | 1,056,774 | 1.1 M to 1.1 M (-0.15 %) |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 37.39 | 400 | 14,956 | 1,058,374 | 1.1 M to 1.1 M (-0.04 %) |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 36.75 | 5,071 | 186,359 | 1,058,774 | 1.1 M to 1.1 M (-0.48 %) |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 36.02 | 14,929 | 537,743 | 1,063,845 | 1.1 M to 1.1 M (-1.38 %) |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 39.23 | 371 | 14,554 | 1,078,774 | 1.1 M to 1.1 M (-0.03 %) |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 38.28 | 100 | 3,828 | 1,079,145 | 1.1 M to 1.1 M (-0.01 %) |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 37.68 | 4,283 | 161,383 | 1,079,245 | 1.1 M to 1.1 M (-0.40 %) |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 36.56 | 7,460 | 272,738 | 1,083,528 | 1.1 M to 1.1 M (-0.68 %) |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 35.59 | 3,100 | 110,329 | 1,090,988 | 1.1 M to 1.1 M (-0.28 %) |
Feb 03 2021 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Sell | S | 34.60 | 4,686 | 162,136 | 1,094,088 | 1.1 M to 1.1 M (-0.43 %) |
Dec 15 2020 | CRTX | Cortexyme, Inc. | Holsinger Leslie | Executive Vice Pres ... | Option Exercise | M | 0.27 | 40,000 | 10,800 | 66,794 | |
Dec 15 2020 | CRTX | Cortexyme, Inc. | Holsinger Leslie | Executive Vice Pres ... | Option Exercise | A | 29.60 | 100,000 | 2,960,000 | 100,000 | |
Dec 15 2020 | CRTX | Cortexyme, Inc. | Holsinger Leslie | Executive Vice Pres ... | Option Exercise | A | 29.60 | 100,000 | 2,960,000 | 100,000 | |
Dec 15 2020 | CRTX | Cortexyme, Inc. | Holsinger Leslie | Executive Vice Pres ... | Sell | S | 32.59 | 900 | 29,331 | 3,500 | 4.4 K to 3.5 K (-20.45 %) |
Dec 15 2020 | CRTX | Cortexyme, Inc. | Holsinger Leslie | Executive Vice Pres ... | Sell | S | 32.59 | 400 | 13,034 | 4,400 | 4.8 K to 4.4 K (-8.33 %) |
Dec 15 2020 | CRTX | Cortexyme, Inc. | Holsinger Leslie | Executive Vice Pres ... | Sell | S | 31.79 | 9,525 | 302,800 | 1,800 | 11.3 K to 1.8 K (-84.11 %) |
Dec 15 2020 | CRTX | Cortexyme, Inc. | Holsinger Leslie | Executive Vice Pres ... | Sell | S | 30.91 | 13,200 | 408,012 | 14,325 | 27.5 K to 14.3 K (-47.96 %) |
Dec 15 2020 | CRTX | Cortexyme, Inc. | Holsinger Leslie | Executive Vice Pres ... | Sell | S | 30.15 | 14,275 | 430,391 | 27,525 | 41.8 K to 27.5 K (-34.15 %) |
Dec 15 2020 | CRTX | Cortexyme, Inc. | Holsinger Leslie | Executive Vice Pres ... | Sell | S | 28.80 | 1,700 | 48,960 | 41,800 | 43.5 K to 41.8 K (-3.91 %) |
Dec 15 2020 | CRTX | Cortexyme, Inc. | Holsinger Leslie | Executive Vice Pres ... | Buy | M | 0.27 | 40,000 | 10,800 | 43,500 | 3.5 K to 43.5 K (+1,142.86 %) |
Dec 15 2020 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Option Exercise | A | 29.60 | 175,000 | 5,180,000 | 175,000 | |
Dec 15 2020 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Option Exercise | A | 29.60 | 175,000 | 5,180,000 | 175,000 | |
Dec 15 2020 | CRTX | Cortexyme, Inc. | Detke Michael J. | Chief Medical Offic ... | Option Exercise | A | 29.60 | 100,000 | 2,960,000 | 100,000 | |
Dec 15 2020 | CRTX | Cortexyme, Inc. | Detke Michael J. | Chief Medical Offic ... | Option Exercise | A | 29.60 | 100,000 | 2,960,000 | 100,000 | |
Dec 15 2020 | CRTX | Cortexyme, Inc. | Dominy Stephen S. | Chief Scientific Of ... | Option Exercise | A | 29.60 | 100,000 | 2,960,000 | 100,000 | |
Dec 15 2020 | CRTX | Cortexyme, Inc. | Dominy Stephen S. | Chief Scientific Of ... | Option Exercise | A | 29.60 | 100,000 | 2,960,000 | 100,000 | |
Dec 15 2020 | CRTX | Cortexyme, Inc. | LOWE CHRISTOPHER P. | Chief Financial Off ... | Option Exercise | A | 29.60 | 100,000 | 2,960,000 | 100,000 | |
Dec 15 2020 | CRTX | Cortexyme, Inc. | LOWE CHRISTOPHER P. | Chief Financial Off ... | Option Exercise | A | 29.60 | 100,000 | 2,960,000 | 100,000 | |
Dec 15 2020 | CRTX | Cortexyme, Inc. | McDowell Caryn Gordon | Chief Legal & Adm. ... | Option Exercise | A | 29.60 | 100,000 | 2,960,000 | 100,000 | |
Dec 15 2020 | CRTX | Cortexyme, Inc. | McDowell Caryn Gordon | Chief Legal & Adm. ... | Option Exercise | A | 29.60 | 75,000 | 2,220,000 | 75,000 | |
Dec 14 2020 | CRTX | Cortexyme, Inc. | Holsinger Leslie | Executive Vice Pres ... | Option Exercise | M | 0.27 | 3,500 | 945 | 106,794 | |
Dec 14 2020 | CRTX | Cortexyme, Inc. | Holsinger Leslie | Executive Vice Pres ... | Buy | M | 0.27 | 3,500 | 945 | 3,500 | 0 to 3.5 K |
Jun 15 2020 | CRTX | Cortexyme, Inc. | EPIQ Capital Group, LLC | Buy | P | 44.06 | 2,440 | 107,506 | 2,860,967 | 2.9 M to 2.9 M (+0.09 %) | |
Jun 15 2020 | CRTX | Cortexyme, Inc. | EPIQ Capital Group, LLC | Buy | P | 44.32 | 6,600 | 292,512 | 2,858,527 | 2.9 M to 2.9 M (+0.23 %) | |
Jun 09 2020 | CRTX | Cortexyme, Inc. | YOUNG KEVIN | Director | Option Exercise | A | 41.73 | 11,029 | 460,240 | 11,029 | |
Jun 09 2020 | CRTX | Cortexyme, Inc. | Senner Christopher J. | Director | Option Exercise | A | 41.73 | 11,029 | 460,240 | 11,029 | |
Jun 09 2020 | CRTX | Cortexyme, Inc. | RYAN UNA S | Director | Option Exercise | A | 41.73 | 11,029 | 460,240 | 11,029 | |
Jun 09 2020 | CRTX | Cortexyme, Inc. | McLoughlin Margaret | Director | Option Exercise | A | 41.73 | 11,029 | 460,240 | 11,029 | |
Jun 09 2020 | CRTX | Cortexyme, Inc. | Lamond David | Director | Option Exercise | A | 41.73 | 11,029 | 460,240 | 11,029 | |
Jun 08 2020 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 43.88 | 24,874 | 1,091,384 | 1,747,109 | 1.7 M to 1.7 M (+1.44 %) |
Jun 08 2020 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 43.32 | 10,642 | 461,034 | 1,722,235 | 1.7 M to 1.7 M (+0.62 %) |
Jun 08 2020 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 42.13 | 13,609 | 573,377 | 1,711,593 | 1.7 M to 1.7 M (+0.80 %) |
Jun 04 2020 | CRTX | Cortexyme, Inc. | PFIZER INC | 10% Owner | Sell | S | 40.18 | 370,000 | 14,866,600 | 2,879,973 | 3.2 M to 2.9 M (-11.38 %) |
May 29 2020 | CRTX | Cortexyme, Inc. | Detke Michael J. | Chief Medical Offic ... | Option Exercise | M | 6.91 | 5,515 | 38,109 | 104,091 | |
May 29 2020 | CRTX | Cortexyme, Inc. | Detke Michael J. | Chief Medical Offic ... | Buy | M | 6.91 | 5,515 | 38,109 | 28,261 | 22.7 K to 28.3 K (+24.25 %) |
May 22 2020 | CRTX | Cortexyme, Inc. | EPIQ Capital Group, LLC | Buy | P | 55.90 | 2,085 | 116,552 | 2,851,927 | 2.8 M to 2.9 M (+0.07 %) | |
May 22 2020 | CRTX | Cortexyme, Inc. | EPIQ Capital Group, LLC | Buy | P | 55.80 | 520 | 29,016 | 2,849,842 | 2.8 M to 2.8 M (+0.02 %) | |
May 22 2020 | CRTX | Cortexyme, Inc. | EPIQ Capital Group, LLC | Buy | P | 57.22 | 417 | 23,861 | 2,849,322 | 2.8 M to 2.8 M (+0.01 %) | |
May 22 2020 | CRTX | Cortexyme, Inc. | EPIQ Capital Group, LLC | Buy | P | 58.00 | 5,668 | 328,744 | 2,848,905 | 2.8 M to 2.8 M (+0.20 %) | |
May 19 2020 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 56.42 | 32,894 | 1,855,738 | 1,697,984 | 1.7 M to 1.7 M (+1.98 %) |
May 19 2020 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 55.42 | 5,906 | 327,309 | 1,665,090 | 1.7 M to 1.7 M (+0.36 %) |
May 19 2020 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 54.09 | 400 | 21,636 | 1,659,184 | 1.7 M to 1.7 M (+0.02 %) |
May 19 2020 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 53.10 | 100 | 5,310 | 1,658,784 | 1.7 M to 1.7 M (+0.01 %) |
May 19 2020 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 52.20 | 500 | 26,101 | 1,658,684 | 1.7 M to 1.7 M (+0.03 %) |
May 19 2020 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 50.71 | 1,000 | 50,707 | 1,658,184 | 1.7 M to 1.7 M (+0.06 %) |
May 19 2020 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 48.96 | 1,600 | 78,333 | 1,657,184 | 1.7 M to 1.7 M (+0.10 %) |
May 19 2020 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 48.37 | 985 | 47,640 | 1,655,584 | 1.7 M to 1.7 M (+0.06 %) |
May 19 2020 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | P | 46.30 | 1,263 | 58,478 | 1,654,599 | 1.7 M to 1.7 M (+0.08 %) |
May 18 2020 | CRTX | Cortexyme, Inc. | Holsinger Leslie | Executive Vice Pres ... | Option Exercise | A | 45.88 | 30,000 | 1,376,400 | 30,000 | |
May 18 2020 | CRTX | Cortexyme, Inc. | LOWE CHRISTOPHER P. | Chief Financial Off ... | Option Exercise | A | 45.88 | 30,000 | 1,376,400 | 30,000 | |
May 15 2020 | CRTX | Cortexyme, Inc. | McDowell Caryn Gordon | Chief Legal & Adm. ... | Option Exercise | A | 45.88 | 200,000 | 9,176,000 | 200,000 | |
Apr 06 2020 | CRTX | Cortexyme, Inc. | Detke Michael J. | Chief Medical Offic ... | Option Exercise | M | 6.91 | 5,515 | 38,109 | 109,606 | |
Apr 06 2020 | CRTX | Cortexyme, Inc. | Detke Michael J. | Chief Medical Offic ... | Buy | M | 6.91 | 5,515 | 38,109 | 22,746 | 17.2 K to 22.7 K (+32.01 %) |
Mar 12 2020 | CRTX | Cortexyme, Inc. | YOUNG KEVIN | Director | Buy | P | 17.00 | 30,000 | 510,000 | 30,000 | 0 to 30 K |
Mar 12 2020 | CRTX | Cortexyme, Inc. | YOUNG KEVIN | Director | Buy | P | 17.00 | 30,000 | 510,000 | 30,000 | 0 to 30 K |
Mar 12 2020 | CRTX | Cortexyme, Inc. | RYAN UNA S | Director | Buy | P | 17.00 | 2,875 | 48,875 | 2,875 | 0 to 2.9 K |
Mar 12 2020 | CRTX | Cortexyme, Inc. | RYAN UNA S | Director | Buy | P | 17.00 | 2,875 | 48,875 | 2,875 | 0 to 2.9 K |
Mar 12 2020 | CRTX | Cortexyme, Inc. | McLoughlin Margaret | Director | Buy | P | 17.00 | 550 | 9,350 | 550 | 0 to 550 |
Feb 10 2020 | CRTX | Cortexyme, Inc. | Lamond David | Director | Grant | A | 50.00 | 30,000 | 1,500,000 | 1,653,336 | 1.6 M to 1.7 M (+1.85 %) |
Feb 10 2020 | CRTX | Cortexyme, Inc. | Detke Michael J. | Chief Medical Offic ... | Option Exercise | M | 6.91 | 17,231 | 119,066 | 115,121 | |
Feb 10 2020 | CRTX | Cortexyme, Inc. | Detke Michael J. | Chief Medical Offic ... | Option Exercise | A | 54.85 | 100,000 | 5,485,000 | 100,000 | |
Feb 10 2020 | CRTX | Cortexyme, Inc. | Detke Michael J. | Chief Medical Offic ... | Buy | M | 6.91 | 17,231 | 119,066 | 17,231 | 0 to 17.2 K |
Feb 10 2020 | CRTX | Cortexyme, Inc. | Gafric Kristen | SVP, Legal & Admini ... | Option Exercise | A | 54.85 | 100,000 | 5,485,000 | 100,000 | |
Feb 10 2020 | CRTX | Cortexyme, Inc. | Dominy Stephen S. | Chief Scientific Of ... | Option Exercise | A | 54.85 | 100,000 | 5,485,000 | 100,000 | |
Feb 10 2020 | CRTX | Cortexyme, Inc. | Holsinger Leslie | Executive Vice Pres ... | Option Exercise | A | 54.85 | 100,000 | 5,485,000 | 100,000 | |
Feb 10 2020 | CRTX | Cortexyme, Inc. | LOWE CHRISTOPHER P. | Chief Financial Off ... | Option Exercise | A | 54.85 | 100,000 | 5,485,000 | 100,000 | |
Feb 10 2020 | CRTX | Cortexyme, Inc. | Lynch Casey | Chief Executive Off ... | Option Exercise | A | 54.85 | 175,000 | 9,598,750 | 175,000 | |
Jan 31 2020 | CRTX | Cortexyme, Inc. | EPIQ Capital Group, LLC | Sell | J | 54.30 | 4,338 | 235,553 | 2,843,237 | 2.8 M to 2.8 M (-0.15 %) | |
Aug 21 2019 | CRTX | Cortexyme, Inc. | EPIQ Capital Group, LLC | Buy | P | 24.87 | 1,635 | 40,660 | 2,834,561 | 2.8 M to 2.8 M (+0.06 %) | |
Aug 21 2019 | CRTX | Cortexyme, Inc. | EPIQ Capital Group, LLC | Buy | P | 24.87 | 420 | 10,445 | 2,832,926 | 2.8 M to 2.8 M (+0.01 %) | |
Aug 21 2019 | CRTX | Cortexyme, Inc. | EPIQ Capital Group, LLC | Buy | P | 25.69 | 2,310 | 59,344 | 2,832,506 | 2.8 M to 2.8 M (+0.08 %) | |
Aug 21 2019 | CRTX | Cortexyme, Inc. | EPIQ Capital Group, LLC | Buy | P | 25.69 | 600 | 15,414 | 2,830,196 | 2.8 M to 2.8 M (+0.02 %) | |
Aug 19 2019 | CRTX | Cortexyme, Inc. | EPIQ Capital Group, LLC | Buy | P | 26.50 | 2,100 | 55,640 | 2,829,596 | 2.8 M to 2.8 M (+0.07 %) | |
Aug 19 2019 | CRTX | Cortexyme, Inc. | EPIQ Capital Group, LLC | Buy | P | 26.37 | 700 | 18,460 | 2,827,496 | 2.8 M to 2.8 M (+0.02 %) | |
Aug 15 2019 | CRTX | Cortexyme, Inc. | Gafric Kristen | SVP, Legal & Admini ... | Option Exercise | A | 28.71 | 75,000 | 2,153,250 | 75,000 | |
Jun 14 2019 | CRTX | Cortexyme, Inc. | EPIQ Capital Group, LLC | Buy | P | 27.05 | 80 | 2,164 | 2,826,796 | 2.8 M to 2.8 M (0.00 %) | |
Jun 14 2019 | CRTX | Cortexyme, Inc. | EPIQ Capital Group, LLC | Buy | P | 27.58 | 4,170 | 115,009 | 2,826,716 | 2.8 M to 2.8 M (+0.15 %) | |
Jun 14 2019 | CRTX | Cortexyme, Inc. | EPIQ Capital Group, LLC | Buy | P | 26.41 | 4,350 | 114,884 | 2,822,546 | 2.8 M to 2.8 M (+0.15 %) | |
May 14 2019 | CRTX | Cortexyme, Inc. | PFIZER INC | 10% Owner | Option Exercise | C | 0.00 | 624,205 | 0 | 0 | |
May 14 2019 | CRTX | Cortexyme, Inc. | PFIZER INC | 10% Owner | Option Exercise | C | 0.00 | 215,697 | 0 | 0 | |
May 14 2019 | CRTX | Cortexyme, Inc. | PFIZER INC | 10% Owner | Option Exercise | C | 0.00 | 2,360,071 | 0 | 0 | |
May 14 2019 | CRTX | Cortexyme, Inc. | PFIZER INC | 10% Owner | Buy | P | 17.00 | 50,000 | 850,000 | 3,249,973 | 3.2 M to 3.2 M (+1.56 %) |
May 14 2019 | CRTX | Cortexyme, Inc. | PFIZER INC | 10% Owner | Buy | C | 0.00 | 624,205 | 0 | 3,199,973 | 2.6 M to 3.2 M (+24.23 %) |
May 14 2019 | CRTX | Cortexyme, Inc. | PFIZER INC | 10% Owner | Buy | C | 0.00 | 215,697 | 0 | 2,575,768 | 2.4 M to 2.6 M (+9.14 %) |
May 14 2019 | CRTX | Cortexyme, Inc. | PFIZER INC | 10% Owner | Buy | C | 0.00 | 2,360,071 | 0 | 2,360,071 | 0 to 2.4 M |
May 13 2019 | CRTX | Cortexyme, Inc. | Takeda Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 319,731 | 0 | 0 | |
May 13 2019 | CRTX | Cortexyme, Inc. | Takeda Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 2,360,071 | 0 | 0 | |
May 13 2019 | CRTX | Cortexyme, Inc. | Takeda Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 2,679,802 | 0 | 2,679,802 | 0 to 2.7 M |
May 13 2019 | CRTX | Cortexyme, Inc. | LAMOND PIERRE | 10% Owner | Option Exercise | C | 0.00 | 462,028 | 0 | 0 | |
May 13 2019 | CRTX | Cortexyme, Inc. | LAMOND PIERRE | 10% Owner | Option Exercise | C | 0.00 | 462,027 | 0 | 0 | |
May 13 2019 | CRTX | Cortexyme, Inc. | LAMOND PIERRE | 10% Owner | Option Exercise | C | 0.00 | 961,510 | 0 | 0 | |
May 13 2019 | CRTX | Cortexyme, Inc. | LAMOND PIERRE | 10% Owner | Option Exercise | C | 0.00 | 500,482 | 0 | 0 | |
May 13 2019 | CRTX | Cortexyme, Inc. | LAMOND PIERRE | 10% Owner | Option Exercise | C | 0.00 | 500,483 | 0 | 0 | |
May 13 2019 | CRTX | Cortexyme, Inc. | LAMOND PIERRE | 10% Owner | Buy | C | 0.00 | 961,510 | 0 | 961,510 | 0 to 961.5 K |
May 13 2019 | CRTX | Cortexyme, Inc. | LAMOND PIERRE | 10% Owner | Buy | C | 0.00 | 962,510 | 0 | 962,510 | 0 to 962.5 K |
May 13 2019 | CRTX | Cortexyme, Inc. | LAMOND PIERRE | 10% Owner | Buy | C | 0.00 | 962,510 | 0 | 962,510 | 0 to 962.5 K |
May 13 2019 | CRTX | Cortexyme, Inc. | Lamond David | Director | Option Exercise | C | 0.00 | 924,056 | 0 | 0 | |
May 13 2019 | CRTX | Cortexyme, Inc. | Lamond David | Director | Option Exercise | C | 0.00 | 301,829 | 0 | 0 | |
May 13 2019 | CRTX | Cortexyme, Inc. | Lamond David | Director | Option Exercise | C | 0.00 | 699,280 | 0 | 0 | |
May 13 2019 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | C | 0.00 | 301,829 | 0 | 301,829 | 0 to 301.8 K |
May 13 2019 | CRTX | Cortexyme, Inc. | Lamond David | Director | Buy | C | 0.00 | 1,623,336 | 0 | 1,623,336 | 0 to 1.6 M |
May 09 2019 | CRTX | Cortexyme, Inc. | McLoughlin Margaret | Director | Option Exercise | A | 17.00 | 91,911 | 1,562,487 | 91,911 |
Page: 1